Purpose: To develop a high resolution microarray based method to detect single- and multiexons gene deletions and duplications. Methods: We have developed a high-resolution comparative genomic ...

Agilent Technologies Inc. has announced that scientists using an Agilent custom-designed comparative genomic hybridization (CGH) array have sequenced the entire gene map of a Korean male. An ...

Purpose: Array-based comparative genomic hybridization is increasingly being used in patients with learning disability, in addition to existing cytogenetic techniques. This paper reports the results ...

Impact of BRCA1 gene alterations on tumor characteristics and clinical outcome in ovarian cancer (OC) patients. Background: Advanced ovarian clear cell carcinomas (OCCCs) are notoriously drug ...

PALO ALTO, Calif., Jan. 5, 2005 -- Agilent Technologies Inc. (NYSE: A) today announced a breakthrough development that enables the rapid advance of microarray-based comparative genomic studies in ...

CHICAGO --The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the ...

Prostate cancer outcomes and polymorphism in LHRH and LH receptors and SHBG. Background: Metastatic CRPC undergoes significant genomic evolution compared to primary, localized disease. Multiple ...

Microarray Market Is Growing as Applications for Diagnostics and Research Are Realized Although DNA microarrays are just beginning to be investigated for diagnostics, they are becoming key tools for ...

This episode features Randy Davis, Vice President and Chief Information Officer at CGH Medical Center. Here, he discusses his 25 years with the same company, his transition into the CIO role, and more ...

Microarray based comparative genomic hybridisation (array CGH) is a new technology with uses developing in various diagnostic areas within the NHS. One important context is the investigation of ...